| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Buprenorphine | FAERS: 1 | US FAERS | |
| 2 | Cladribine | FAERS: 1 | US FAERS | |
| 3 | Clozapine | FAERS: 1 | US FAERS | |
| 4 | Darunavir | FAERS: 1 | US FAERS | |
| 5 | Deferasirox | FAERS: 1 | US FAERS | |
| 6 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | FAERS: 1 | US FAERS | |
| 8 | Emtricitabine, Rilpivirine, Tenofovir Drug Combination | FAERS: 1 | US FAERS | |
| 9 | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | FAERS: 1 | US FAERS | |
| 10 | Naltrexone | FAERS: 1 | US FAERS | |
| 11 | Nitrofurantoin | FAERS: 1 | US FAERS | |
| 12 | Prezcobix | FAERS: 1 | US FAERS | |
| 13 | Rifaximin | FAERS: 1 | US FAERS | |
| 14 | Tacrolimus | FAERS: 1 | US FAERS | |
| 15 | Viekira Pak | FAERS: 1 | US FAERS | |
| 16 | entecavir | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.